Virtus ETF Advisers’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,770
Closed -$66.1K 470
2024
Q4
$66.1K Sell
1,770
-990
-36% -$46.2K 0.03% 411
2024
Q3
$138K Buy
2,760
+50
+2% +$1.95K 0.06% 334
2024
Q2
$94.1K Buy
2,710
+407
+18% +$16.1K 0.05% 339
2024
Q1
$126K Sell
2,303
-156
-6% -$7.72K 0.07% 344
2023
Q4
$105K Sell
2,459
-1,598
-39% -$49.7K 0.07% 338
2023
Q3
$106K Sell
4,057
-403
-9% -$8.38K 0.06% 330
2023
Q2
$107K Sell
4,460
-1,978
-31% -$34K 0.06% 351
2023
Q1
$87.9K Sell
6,438
-2,478
-28% -$39.4K 0.05% 366
2022
Q4
$124K Buy
+8,916
New +$126K 0.06% 411

Other funds holding BHVN

Virtus ETF Advisers's BHVN Position: Q1 2025 in Review

Virtus ETF Advisers sold out of Biohaven (BHVN) in Q1 2025, closing a stake of 1,770 shares — an estimated $66.1K sold.

Virtus ETF Advisers first reported a position in BHVN in Q4 2022 and held it in 9 quarters. The position peaked at $138K in Q3 2024. 266 funds tracked by Wall St. Rank hold BHVN as of Q1 2025.

  • Virtus ETF Advisers reported no remaining Biohaven position as of Q1 2025 after selling out during the quarter.
  • Virtus ETF Advisers sold 1,770 Biohaven shares in Q1 2025, an estimated $66.1K.
  • Virtus ETF Advisers first reported a position in Biohaven in Q4 2022 and held it in 9 quarters.
  • Virtus ETF Advisers's Biohaven position peaked at $138K in Q3 2024.
  • 266 funds tracked by Wall St. Rank held Biohaven as of Q1 2025.

Based on Virtus ETF Advisers's 13F filing for Q1 2025, filed 14 May 2025.